CAS 204656-20-2

(4S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-5-hyd

Description:

The chemical substance with the name "(4S)-5-[[[5S)-5-[[[2S)-2-[[[2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-5-hyd" and CAS number "204656-20-2" is a complex peptide with multiple stereocenters, indicating that it is likely to exhibit chirality, which can influence its biological activity and interactions. This substance is characterized by a series of amino acid residues, including imidazole, which suggests potential roles in biological systems, possibly as a signaling molecule or in enzyme catalysis. The presence of multiple amino groups and carboxylic acid functionalities indicates that it may have significant solubility in polar solvents and could participate in various biochemical reactions. Its intricate structure may also suggest specific conformational properties that are crucial for its function in biological contexts. Overall, this compound exemplifies the complexity often found in biologically active peptides and proteins.

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

InChI: InChI=1/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-128(223)193-112(59-64-132(227)228)148(244)180-68-41-40-50-111(154(250)199-116(62-67-135(233)234)155(251)204-120(73-100-44-33-31-34-45-100)160(256)214-140(93(11)19-2)168(264)192-97(15)146(242)201-122(76-103-79-183-108-49-39-38-48-106(103)108)158(254)203-118(72-90(5)6)159(255)212-138(91(7)8)166(262)200-110(52-43-70-182-172(177)178)150(246)184-81-129(224)194-109(51-42-69-181-171(175)176)149(245)187-84-137(237)238)196-144(240)95(13)189-143(239)94(12)191-153(249)115(58-63-127(174)222)195-130(225)82-185-152(248)114(61-66-134(231)232)198-156(252)117(71-89(3)4)202-157(253)119(75-102-54-56-105(221)57-55-102)205-163(259)124(85-216)208-165(261)126(87-218)209-167(263)139(92(9)10)213-162(258)123(78-136(235)236)206-164(260)125(86-217)210-170(266)142(99(17)220)215-161(257)121(74-101-46-35-32-36-47-101)207-169(265)141(98(16)219)211-131(226)83-186-151(247)113(60-65-133(229)230)197-145(241)96(14)190-147(243)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,244)(H,184,246)(H,185,248)(H,186,247)(H,187,245)(H,189,239)(H,190,243)(H,191,249)(H,192,264)(H,193,223)(H,194,224)(H,195,225)(H,196,240)(H,197,241)(H,198,252)(H,199,250)(H,200,262)(H,201,242)(H,202,253)(H,203,254)(H,204,251)(H,205,259)(H,206,260)(H,207,265)(H,208,261)(H,209,263)(H,210,266)(H,211,226)(H,212,255)(H,213,258)(H,214,256)(H,215,257)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1

Synonyms:

• Liraglutida [INN-Spanish]
• Liraglutide
• Liraglutidum [INN-Latin]
• Nn 2211
• Nn2211
• Unii-839I73S42A
• Liraglutide [usan:inn]
• Liroglutide
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
• Liraglutide /Liraglutide Acetate
• Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-
• HAEGTFTSDVSSYLEGQAAK [N-(1-oxohexadecyl)-L-γ-glutaMyl] EFI AWLVRGRG
• (Lys(g-Glu-palMitoyl)26,Arg34)-GLP-1 (7-37)
• Liraglutida
• Liraglutide, (Lys(γ-Glu-palmitoyl)26,Arg34)-GLP-1 (7-37)
• (Lys(γ-Glu-palMitoyl)26,Arg34)-GLP-1 (7-37)
• H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(g-Glu-palMitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
• Liraglutidum
• Liraglutide Impurity
• Liraglutide injection
• Liraglutide, NN2211
• NNC 90-1170
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
• Victoza

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purity: 99%

Color and Shape: Solid

Molecular weight: 3751.2020

Ref: IN-DA003RAK

Liraglutide-d8 Tetratrifluoroacetate

CAS: 204656-20-2

Formula: C₁₇₂H₂₅₇D₈N₄₃O₅₁·4C₂HF₃O₂

Molecular weight: 3759.31 4*114.02

Ref: 4Z-PL-105047

Liraglutide

CAS: 204656-20-2

Liraglutide

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Color and Shape: Solid

Molecular weight: 3751.0

Ref: 54-BI9895

Liraglutide-d8 Tritrifluoroacetate

CAS: 204656-20-2

Formula: C₁₇₂H₂₅₇D₈N₄₃O₅₁·3C₂HF₃O₂

Color and Shape: White To Off-White Solid

Molecular weight: 3759.31 3*114.02

Ref: 4Z-PL-105002

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Color and Shape: White To Off-White Solid

Molecular weight: 3751.26

Ref: 4Z-PL-105001

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purity: 95%~99%

Color and Shape: White to Off-white Powder

Molecular weight: 3751. 20

Ref: BP-BPPG046

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purity: ≥ 98.0%

Color and Shape: White to off-white powder

Molecular weight: 3751.2

Ref: 7W-GX3695

Liraglutide

CAS: 204656-20-2

Liraglutide (Liraglutida) is a synthetic analog of GLP-1, an agonist of the GLP-1 receptor. Liraglutide is an antidiabetic agent. Cost effective and quality assured.

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purity: 97.65% - 99.04%

Color and Shape: White Solid

Molecular weight: 3751.25

Ref: TM-T6876

Liraglutide

Controlled Product

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Color and Shape: Neat

Molecular weight: 3751.2

Ref: TR-L468860

Liraglutide sodium

CAS: 204656-20-2

Please enquire for more information about Liraglutide sodium  including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formula: C₁₇₂H₂₆₅N₄₃O₅₁•(Na)x

Ref: 3D-BL184581

Liraglutide acetate

CAS: 204656-20-2

Liraglutide is a glucagon-like peptide-1 analog that has been shown to be an effective treatment for obesity. Liraglutide targets the adipose tissue and reduces the amount of glucose in the blood by increasing insulin sensitivity, lowering food intake, and reducing appetite. In addition, Liraglutide has been shown to suppress postprandial hyperglycemia and lower plasma glucose levels in patients with type 2 diabetes mellitus. Liraglutide also inhibits neuronal death induced by apoptotic stimuli, which may have potential use as a model system for neurodegenerative diseases such as Parkinson's disease. Liraglutide has also been shown to be an effective therapy for infectious diseases including Crohn's disease and ulcerative colitis. This drug has shown some effectiveness against atherosclerosis in animal models by inducing apoptosis in macrophages that are associated with lesions.

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purity: Min. 95%

Molecular weight: 3,751.29 g/mol

Ref: 3D-PGL-3781-PI

Liraglutide

CAS: 204656-20-2

Glucagon-like peptide 1 (GLP-1) receptor agonist; hypoglycemic agent

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purity: Min. 95 Area-%

Color and Shape: White Powder

Molecular weight: 3,751.2 g/mol

Ref: 3D-FL109949

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Molecular weight: 3751.26

Ref: ST-EA-CP-L86000

Liraglutide trifluoroacetate salt

CAS: 204656-20-2

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and used to treat diabetes mellitus type 2 and obesity. The GLP-1 receptor agonists stimulate insulin secretion and inhibit glucagon secretion.

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purity: 98.9%

Molecular weight: 3751.26

Ref: 01-4041752